Build better medicines through evidence, consistency, and safety
Established narrow medical uses · New indications require evidence. Specific cannabinoid medicines have specific evidence. The US FDA has approved purified cannabidiol for certain seizure disorders; that does not validate every cannabis preparation or establish Philippine approval. Select the first indication through an independent review of clinical evidence, unmet patient need, alternatives, and local feasibility. Include adverse effects and interactions in the same review as potential benefits.
Established narrow medical uses · New indications require evidence. This page expands the “Build better medicines through evidence, consistency, and safety” chapter in the cannabis collection.
Specific cannabinoid medicines have specific evidence. The US FDA has approved purified cannabidiol for certain seizure disorders; that does not validate every cannabis preparation or establish Philippine approval. Select the first indication through an independent review of clinical evidence, unmet patient need, alternatives, and local feasibility. Include adverse effects and interactions in the same review as potential benefits.
The proposed centers should compare verified product composition and quality rather than treat strain names as standardized interventions. Qualified laboratories would assess identity, consistency, contaminants, stability, and the suitability of each product for its intended study. A Philippine formulation cannot be assumed equivalent to a US product because both carry a cannabis label.
Making cannabis better with technology should mean reproducible quality, clearer therapeutic benefit, lower avoidable harm, and affordable access. Higher potency is not itself progress. Require a product-specific development plan, independent verification, and a publication record that includes failures before making efficacy or superiority claims in either country.
Open this exact section in the Necromancer dossier. The original chapter status is “Established narrow medical uses · New indications require evidence.”
Take this topic further
Turn “Build better medicines through evidence, consistency, and safety” into a learning path
The Learning Studio will use this page’s overview and key ideas to shape a guided lesson, practice questions, and a small project around what you want to understand.
Related GiveGigs pages and features
Explore connected GiveGigs pages and tools for context and next steps.